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A Rapid and Simple Method for Determination of 5-Hydroxytryptophan in Dietary 
Supplements by Capillary Electrophoresis
Aline G. Coelho,a Fernanda P. C. Aguiara and Dosil P. de Jesus*,a,b
aInstitute of Chemistry and bInstituto Nacional de Ciência e Tecnologia de Bioanalítica,  
University of Campinas (UNICAMP), P.O. Box 6154, 13083-970 Campinas-SP, Brazil
Neste trabalho é apresentado o desenvolvimento de um método rápido e simples, empregando 
eletroforese capilar, para determinação de 5-hidroxitriptofano (5-HTP) em amostras de 
suplementos alimentares. O eletrólito de corrida utilizado foi constituído por 20 mmol L−1 de 
fosfato de sódio (pH 10) e 0,2 mmol L−1 de brometo de cetiltrimetilamônio (CTAB), empregado 
como inversor de fluxo eletrosmótico. Foram obtidos limites de detecção e quantificação de 3,1 
e 10,1 µmol L−1, respectivamente. A curva analítica obtida, para concentrações do analito entre 
0-500 µmol L−1, apresentou linearidade com coeficiente de correlação linear (R2) de 0,9995. A 
precisão instrumental intra-dia (repetibilidade), expressa em desvio padrão relativo (RSD), para 
a área de pico e tempo de migração do 5-HTP foram de 2,2 e 1,9% (n = 8), respectivamente. 
O método eletroforético foi empregado na análise de quatro diferentes amostras comerciais de 
suplementos alimentares e o RSD (n = 3) para as determinações variaram de 2 a 3%. A exatidão 
do método foi avaliada pela comparação das concentrações de 5-HTP obtidas pelo método 
proposto e por cromatografia líquida de alta eficiência (HPLC). Os erros relativos variaram 
entre 0 e 5,9% e não foram observadas diferenças significativas entre as concentrações, ao nível 
de 95% de confiança.
A rapid and simple capillary electrophoresis (CE) method was developed to determine 
5-hydroxytryptophan (5-HTP) in samples of commercial dietary supplements. The optimized 
background electrolyte (BGE) was composed by 20 mmol L−1 sodium phosphate (pH 10) and 
0.2 mmol L−1 cetyltrimethylammonium bromide (CTAB) for electroosmotic flow inversion. The 
limits of detection (LOD) and quantification (LOQ) for 5-HTP were 3.1 and 10.1 µmol L−1, 
respectively. The analytical curve demonstrated linearity over a concentration range of 
0-500 µmol L−1 with a correlation coefficient (R2) of 0.9995. The intraday instrumental precision 
(repeatability) as relative standard deviation (RSD) in terms of peak area and migration time of the 
5-HTP were 2.2 and 1.9% (n = 8), respectively. The CE method was applied to the analysis of four 
different samples of commercial dietary supplements and the RSD (n = 3) for the determinations 
ranged from 2 to 3%. The accuracy of the method was evaluated comparing the measured 5-HTP 
concentrations to those obtained by a high performance liquid chromatography (HPLC) method. 
The relative error ranged from 0 to 5.9% (n = 3) and no significant differences between the 
concentrations were observed at a confidence level of 95%. 
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Introduction
The use of complementary and alternative medicines 
for the treatment of physical and mental health problems 
has been increasing in the last decade worldwide.1,2 Natural 
medications for mood disorders, such as depression, anxiety, 
and insomnia are among the most popular. An example is 
the commercialization of 5-hydroxytryptophan (5-HTP) 
as dietary supplements for the treatment of depression, 
obesity, fibromyalgia, insomnia, chronic headaches, and 
also as a potent antioxidant.3 The 5-HTP is an aromatic 
amino acid synthesized in vivo from the essential amino 
acid tryptophan by the enzyme tryptophan hydroxylase 
(Figure 1).1,4 After entering the central nervous system, the 
5-HTP is converted to serotonin (5-hydroxytyptamine) by 
the enzyme tryptophan decarboxylase.5,6
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Serotonin is a neurotransmitter and vasoconstrictor in 
the central nervous system, responsible for the modulation 
of anger, aggression, mood, sexuality, appetite, and 
muscle contraction. Some authors have reported7,8 that low 
serotonin levels can lead to depression disease. As 5-HTP 
and tryptophan are precursors in the serotonin synthesis 
(Figure 1), the ingestion of these amino acids has been 
studied for the treatment of depression.1 For this propose, 
the 5-HTP has some advantages, once it is converted 
more quickly to serotonin because it easily crosses the 
barrier blood-brain, while the tryptophan needs a carrier 
molecule.1,9 Moreover, tryptophan requires an additional 
step (conversion to 5-HTP) in the serotonin synthesis 
pathway.
Currently, commercial supplements of 5-HTP 
are obtained from seeds of an African plant called 
Griffonia simplicifolia. In the USA, dietary supplement 
formulations containing 5-HTP, vitamins, and preservatives 
can be purchased from health-food stores and drugstores 
without medical prescription. The main benefits of taking 
5-HTP dietary supplements are effectiveness as standard 
antidepressants, mood enhancement, helping in weight 
loss, and aiding sleeping.
There is an increasing tendency towards using 5-HTP 
as alternative and natural medication for treatment of 
mood disorders and obesity, so the development of 
analytical methods for determination of this amino acid 
in dietary supplements, biological fluids, and other 
matrices has gained great attention. High performance 
liquid chromatography (HPLC) methods have been used 
for determination of 5-HTP and other indoleamines, such 
as tryptophan and serotonin, in rat brain tissue,10 coffee,9 
human serum,11 fruiting bodies of edible mushroom,12 
chocolate,7 milk-based ingredients, and dried sport 
supplements.13 Electrochemical14-16 and ultraviolet-
visible16 spectroscopy methods have also been used for 
determination of 5-HTP.
Capillary electrophoresis (CE) can be advantageous for 
determination of 5-HTP, since this technique can provide 
high separation efficiency and short analysis time with 
consumption of low volumes of sample and background 
electrolyte (BGE).17 However, few works have reported 
the use of CE for determination of 5-HTP in standard 
solutions,18,19 urine,20-22 serum,22,23 neuronal extracts,24 
medical syrup,25 and human plasma.26 In addition, most of 
these works employed amperometric,19,20 fluorescence,21-24 
and mass spectrometry26 detection methods instead of 
ultraviolet (UV) detection that is the most commonly used 
in commercial CE systems.
In this paper, a simple and rapid method for determination 
of 5-HTP in dietary supplements using CE with UV 
detection is proposed. This method required simple sample 
preparation steps such as dissolving samples in water, 
filtration, and appropriated dilution in the CE BGE. To the 
best of our knowledge, this is the first work reporting the 
analysis of 5-HTP dietary supplements by CE.
Experimental
Reagents and solutions
All reagents were of analytical grade except methanol, 
which was HPLC grade. Sodium hydroxide, sodium 
phosphate, and phosphoric acid were purchased from 
Labsynth (Diadema, SP, Brazil). Potassium hydrogen 
phthalate was from Vetec (Rio de Janeiro, RJ, Brazil). 
Cetyltrimethyl ammonium bromide (CTAB) and 
L-tryptophan were purchased from Sigma-Aldrich 
(Steinheim, Germany), and 5-HTP was from Acros (New 
Jersey, USA). Methanol was from Tedia (Fairfield, OH, 
USA). Ultra-pure water was obtained from Direct-Q 3 UV 
Water Purification System (Millipore, Molsheim, France). 
The BGE was composed by 20 mmol L−1 sodium phosphate 
and 0.2 mmol L−1 CTAB for electroosmotic flow inversion. 
The pH of the BGE was adjusted to 10 with sodium 
hydroxide aqueoussolution (0.1 mol L−1). Stock solution 
of 5-HTP (10 mmol L−1) was prepared by dissolving the 
solid reagent in ultra-pure water. Standard solutions of 
5-HTP were prepared by dilution of the stock solution 
with ultra-pure water or BGE, as required. Phthalate (as 
potassium hydrogen phthalate) was added (100 µmol L−1) 
to all solutions as an internal standard.
Sample preparation
Four different commercial dietary supplements 
containing 5-HTP were purchased from pharmacy stores in 
the USA. The samples were crushed (tablets) or removed 
Figure 1. Biosynthesis pathway of serotonin from tryptophan.
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from the capsules (pills), and 0.0400 g of the powdered 
samples was then dissolved under sonication (for 30 min) 
in 250 mL of ultra-pure water. For CE analysis, the sample 
solutions of each dietary supplement were diluted with 
BGE and the internal standard was then added. For HPLC 
analysis, the samples solutions were only diluted with 
ultra-pure water. The diluted sample solutions were filtered 
through a membrane filter (0.22 µm) before injection into 
CE or HPLC systems.
Instrumentation and procedure
CE analyses
CE analyses were performed in an Agilent 7100 
capillary electrophoresis system (Agilent, Waldbronn, 
Germany) equipped with a diode array detector. The CE 
method employed a bare fused silica capillary of 60 cm 
total length, 52.5 cm effective length, and 50 µm internal 
diameter. The sample solutions were hydrodynamically 
injected into the capillary using 50 mbar pressure for 4 s. 
The separation voltage was −20 kV and the UV detection 
was performed at 214 nm with a data acquisition rate of 
2.5 Hz. Before the first run of the day, the capillary was 
flushed with 1 mol L−1 NaOH aqueous solution for 5 min, 
then with ultra-pure water for 5 min, and finally with the 
BGE for 5 min.
HPLC analyses
The accuracy of the proposed method was evaluated 
by comparison with a HPLC method adapted from a 
reference method for determination of tryptophan.27 
The HPLC analyses were performed using an Agilent 
HPLC 1200 Series (Agilent, Waldbronn Germany). The 
analytical column was a C18 Zorbax Eclipse plus (5 mm, 
4.6 mm × 250 mm). The mobile phase consisted of sodium 
acetate aqueous solution (8.5 mmol L−1), with pH 4.0 
adjusted with acetic acid/methanol (95:5, v/v), at a flow rate 
of 1.5 mL min−1. UV detection was performed at 280 nm.
Results and Discussion
CE Separation
The optimization of the CE parameters was important 
to attain fast and efficient separation. The pH of the BGE 
was adjusted to 10.0 because at high pH values the 5-HTP 
has a net negative charge caused by the full ionization 
of its carboxylic acid group (pKa = 2.7) and the partial 
protonation of the amine group (pKa = 9.6) and the hydroxyl 
group (pKa = 10.7) on the indole ring. Figure 2 shows 
an electropherogram of a standard solution containing 
5-HTP and tryptophan. Separation of tryptophan was 
also evaluated because this amino acid is the precursor 
of 5-HTP (Figure 1) and may be present in the analyzed 
dietary supplements. Figure 2 shows that these amino 
acids could be baseline separated and the 5-HTP showed 
a higher electrophoretic mobility (shorter migration time) 
than tryptophan. This difference can be explained by the 
presence of the hydroxyl group in the 5-HTP that is partially 
ionized at the pH of the BGE.
The noticeable asymmetry in the peak shape, 
mainly for phthalate and tryptophan, can be ascribed 
to electrodispersion, an intrinsic phenomenon in 
electrophoretic process caused by differences in mobilities 
between the analyte zones and the BGE. Despite this 
electrodispersion, good peak resolution was achieved.
The inversion of the eletroosmotic flow, by adding 
CTAB in the BGE, contributed to a reduced separation 
time of less than 7 min. Phthalate was demonstrated to be 
a good internal standard because it was not present in the 
samples and its migration time was very close to those of 
the analytes.
Figures 3a and 3b show electropherograms of a standard 
solution of 5-HTP (300 µmol L−1) and a dietary supplement 
sample, respectively. For some samples, slight shifts in the 
migration time for the 5-HTP peak were observed and can 
more likely be attributed to variation in the electroosmotic 
flow intensity or influence of the sample composition (ionic 
strength). Nevertheless, the identity of the 5-HTP peak was 
confirmed by spiking experiments. Although vitamins, 
additives, and excipients were present in the samples, no 
Figure 2. Electropherogram of a standard solution of 5-HTP and 
tryptophan (300 µmol L−1 each). BGE: 20 mmol L−1 sodium phosphate 
(pH 10) and 0.2 mmol L−1 CTAB for electroosmotic flow inversion. Fused 
silica capillary column with 50 µm internal diameter (i.d.) and 60 cm length 
(52.5 cm effective). Separation voltage of −20 kV; pressure injection at 
50 mbar for 4 s; detection wavelength of 214 nm. Peaks: (1) phthalate 
(internal standard); (2) 5-HTP; (3) tryptophan.
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interference peaks were observed, demonstrating a good 
selectivity of the proposed method. 
The CE method demonstrated a good recovery (95%) 
for a sample spiked with tryptophan at 300 µmol L−1 
(Figure 3c), suggesting the proposed method can also be 
used to evaluate contamination or intentional adulteration of 
5-HTP dietary supplements with tryptophan. Nevertheless, 
the analyzed samples showed tryptophan concentration 
lower than the limit of detection (LOD).
Figures of merit of the CE method
To ensure the applicability of the proposed method, 
the main figures of merit were evaluated according to 
the recommendations described in the literature28 and the 
results are summarized in Table 1. The linearity of the 
analytical curve over a wide range of 5-HTP concentrations 
(0-500 µmol L−1) was evidenced by the high value of the 
regression coefficient (R2 = 0.9995). The instrumental 
precision was evaluated by consecutive injections (n = 8) 
of a standard solution of 5-HTP (200 µmol L−1) and the 
relative standard deviation (RSD) was 2.2% in terms of 
peak area and 1.92% for the migration time.
Analyses of dietary supplements 
The feasibility and usefulness of the developed CE 
method was evaluated by the determination of 5-HTP in 
four different samples of commercial dietary supplements. 
The labeled concentration of 5-HTP in the samples was 
100 mg per tablet (or pill) except for one sample that was 
200 mg per tablet. Table 2 shows the results obtained by 
the proposed CE method and the HPLC method used 
for comparison. The RSD (n = 3) for the determinations 
ranged from 2 to 3 % for the CE method and 0.5 to 6% 
for the HPLC method. By the Student’s t-test (Table 2), 
no statistically significant differences between the 
concentrations measured by the methods were found at a 
confidence level of 95%. 
Conclusions
The consumption of 5-HTP as a dietary supplement 
has increased worldwide since evidence emerged 
suggesting this amino acid can be an alternative and 
natural medication for treatment of mood disorders and 
obesity. Thus, the development of analytical methods for 
determination of 5-HTP in many sample matrices will 
attract great attention in the coming years. In this context, 
this work has contributed to demonstrating that CE can be 
a suitable technique for fast and simple determination of 
5-HTP in dietary supplements, as well as for detection of 
contamination/adulteration with tryptophan. 
Figure 3. Electropherograms of (a) a standard solution of 5-HTP 
(300 µmol L−1), (b) a sample of dietary supplement, and (c) a sample 
of dietary supplement spiked with tryptophan (300 µmol L−1). Phthalate 
(100 µmol L−1) was added to the solutions as internal standard. Separation 
conditions as in Figure 2. Peaks: (1) phthalate (internal standard), 
(2) 5-HTP, (3) tryptophan.
Table1. Figures of merit of the method
Migration time / mina 5.2 ± 0.1
N / mb 158,093
Regression equationc Y = 2.5 × 10−3x − 1.15 × 10−2
LOD / (µmol L−1)d 3.1
LOQ / (µmol L−1)e 10.1
Linear range / (µmol L−1)f 0-500
R2 0.9995
aMean and standard deviation for 8 consecutive replicate runs; bnumber of 
plates per meter calculated from N/m = 5.54 (tm/w1/2)
2/L, where tm is the 
migration time, w1/2 is the peak width at half height, and L is the effective 
capillary length; cx = concentration of 5-HTP (µmol L−1); y = ratio of peak 
area of 5-HTP to that of internal standard; dS/N = 3; eS/N = 10; fn = 3.
Table 2. Results of the comparison between CE and HPLC methods
Sample
Concentration measured 




1 206 ± 6 199 ± 1 3.5 1.99
2 96 ± 2 102 ± 4 −5.9 2.32
3 108 ± 5 105 ± 4 2.9 0.81
4 94 ± 2 94 ± 6 0 0
amg per tablet or pill; SD = standard deviation (n = 3); brelative error; 
ccalculated Student’s t-value; 2.78 is the tabulated t-value at a confidence 
level of 95% and 4 degrees of freedom. 
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